United States Steel, Ocwen Financial, Immune Pharmaceuticals Stocks Moving Today

Three stocks making big moves on the charts today are United States Steel, Ocwen Financial, and Immune Pharmaceuticals

by Josh Selway |

Published on Apr 20, 2017 at 3:13 PM

The Dow is on pace for a triple-digit win, amid the latest round of corporate earnings. Among specific stocks on the move this afternoon are steel stock United States Steel Corporation (NYSE:X), mortgage company Ocwen Financial Corp (NYSE:OCN), and biotech Immune Pharmaceuticals Inc (NASDAQ:IMNP). Here's a quick look at what's moving shares of X, OCN, and IMNP.

United States Steel Rallies as Trump Cracks Down on Imports

Steel stocks are rallying today, after President Trump launched an investigation to see how imported steel affects the economy and national security. The news has X stock up 8.4% at $30.80, though this still leaves the shares below their year-to-date breakeven point of $33.01. However, the move should be a boon for United States Steel Corporation options traders. X shares have a 10-day call/put volume ratio of 2.66 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) -- an annual high. In other words, speculators are extremely optimistic ahead of U.S. Steel earnings, due next Tuesday evening.

Ocwen Financial Falls 50% on Lawsuit

OCN has lost over half of its value today to trade at $2.51, amid news the company is being sued by U.S. regulators. Ocwen Financial Corp stock is now on pace for its lowest close since August, and short sellers have to be delighted -- though the shares are short-sale restricted today. Specifically, short interest on OCN stock increased by almost 24% during the past two reporting periods, and now accounts for roughly 17% of its float. 

Immune Pharmaceuticals Explodes on Ceplene News

IMNP has soared 45.7% today to trade at $3.55, after the company announced plans to sell the Latin America licensing rights for its leukemia treatment, Ceplene, to Pint Pharma. While the stock is closing in on positive year-to-date territory, it remains well below its 52-week high of $12.80, and short sellers are counting on further losses. Immune Pharmaceuticals Inc has over 10 million shares sold short, or 8.3% of its float -- which would take a week to cover, at the stock's average daily trading volume.

JOIN FREE

Get Schaeffer's Opening View every morning before the bell rings.


MORE | MARKETstories


Dow Ekes Out a Win Thanks to Travelers
Concerns over the iPhone 8 and Apple Watch sparked Apple's worst day since August
Procter & Gamble Options Traders Eye Record Highs By Tomorrow's Close
Options buyers have targeted PG's October 97.50 call in recent months
Verizon, Philip Morris Stocks Head Opposite Directions After Earnings
Philip Morris stock is lower after an earnings miss
The Most Overbought Stocks and Sectors Right Now
Plus, the 20 most oversold stocks

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

TRADING SERVICES | FEATUREDproducts


By MG 2016
In March of 2016, I was introduced to Expiration Week Countdown.  The results are better than words!
Options trading made simple.
Schaeffer's Investment Research, Inc. is dedicated to providing subscribers advantages in options trading and investing.  Our independent market research services create profitable opportunities for investors at every level.